GE HealthCare Technologies Forecast, price target & analysts
GE HealthCare Technologies Target price 2026 - Analyst rating & recommendation
GE HealthCare Technologies Classifications & Recommendation
GE HealthCare Technologies Price Target
| Target Price | $90.78 |
| Price | $82.60 |
| Potential | 9.90% |
| Number of Estimates | 25 |
| 25 Analysts have issued a price target GE HealthCare Technologies 2027 . The average GE HealthCare Technologies target price is $90.78. This is 9.90% higher than the current stock price. The highest price target is $105.00 27.12% , the lowest is $73.73 10.74% . | |
| A rating was issued by 29 analysts: 21 Analysts recommend GE HealthCare Technologies to buy, 8 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the GE HealthCare Technologies stock has an average upside potential 2027 of 9.90% . Most analysts recommend the GE HealthCare Technologies stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2032
25 Analysts have issued a sales forecast GE HealthCare Technologies 2026 . The average GE HealthCare Technologies sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
18 Analysts have issued an GE HealthCare Technologies EBITDA forecast 2026. The average GE HealthCare Technologies EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
26 GE HealthCare Technologies Analysts have issued a net profit forecast 2026. The average GE HealthCare Technologies net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032
26 Analysts have issued a GE HealthCare Technologies forecast for earnings per share. The average GE HealthCare Technologies EPS is
. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .This results in the following potential growth metrics and future valuations:
GE HealthCare Technologies...
Current GE HealthCare Technologies Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Neutral
➜
Neutral
|
Unchanged | Nov 03 2026 |
| JP Morgan |
Neutral
➜
Neutral
|
Unchanged | Oct 29 2026 |
| RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Oct 29 2026 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Oct 29 2026 |
| Citigroup |
Neutral
➜
Neutral
|
Unchanged | Oct 29 2026 |
| BTIG |
Buy
➜
Buy
|
Unchanged | Oct 28 2026 |
| BTIG |
Buy
➜
Buy
|
Unchanged | Oct 12 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Nov 03 2026 |
|
Unchanged
JP Morgan:
Neutral
➜
Neutral
|
Oct 29 2026 |
|
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Oct 29 2026 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Oct 29 2026 |
|
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Oct 29 2026 |
|
Unchanged
BTIG:
Buy
➜
Buy
|
Oct 28 2026 |
|
Unchanged
BTIG:
Buy
➜
Buy
|
Oct 12 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
